1. Home
  2. LUCY vs TRIB Comparison

LUCY vs TRIB Comparison

Compare LUCY & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$0.84

Market Cap

7.4M

Sector

Health Care

ML Signal

HOLD

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

SELL

Current Price

$6.57

Market Cap

8.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LUCY
TRIB
Founded
2017
1992
Country
United States
Ireland
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
LUCY
TRIB
Price
$0.84
$6.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 155.4K
10.6K
Earning Date
11-12-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.39
N/A
EPS
N/A
★ N/A
Revenue
★ $2,661,669.00
N/A
Revenue This Year
$170.51
$35.89
Revenue Next Year
$205.56
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 62.65
N/A
52 Week Low
$0.65
$0.28
52 Week High
$2.02
$14.17

Technical Indicators

Market Signals
Indicator
LUCY
TRIB
Relative Strength Index (RSI) 41.85 56.32
Support Level $0.80 $0.53
Resistance Level $0.97 $14.03
Average True Range (ATR) 0.04 1.03
MACD -0.01 0.18
Stochastic Oscillator 7.48 91.38

Price Performance

Historical Comparison
LUCY
TRIB

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: